145 related articles for article (PubMed ID: 22118994)
1. A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist.
Garmes HM; Grassiotto OR; Fernandes YB; Queiroz Lde S; Vassalo J; de Oliveira DM; Benetti-Pinto CL
Fertil Steril; 2012 Jan; 97(1):231-4. PubMed ID: 22118994
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma.
Roberts JE; Spandorfer S; Fasouliotis SJ; Lin K; Rosenwaks Z
Fertil Steril; 2005 Jan; 83(1):208-10. PubMed ID: 15652911
[TBL] [Abstract][Full Text] [Related]
3. Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation.
Djerassi A; Coutifaris C; West VA; Asa SL; Kapoor SC; Pavlou SN; Snyder PJ
J Clin Endocrinol Metab; 1995 Feb; 80(2):591-4. PubMed ID: 7852525
[TBL] [Abstract][Full Text] [Related]
4. A functioning FSH-secreting pituitary macroadenoma causing an ovarian hyperstimulation syndrome with multiple cysts resected and relapsed after leuprolide in a reproductive-aged woman.
Macchia E; Simoncini T; Raffaelli V; Lombardi M; Iannelli A; Martino E
Gynecol Endocrinol; 2012 Jan; 28(1):56-9. PubMed ID: 21770827
[TBL] [Abstract][Full Text] [Related]
5. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma.
Shimon I; Rubinek T; Bar-Hava I; Nass D; Hadani M; Amsterdam A; Harel G
J Clin Endocrinol Metab; 2001 Aug; 86(8):3635-40. PubMed ID: 11502789
[TBL] [Abstract][Full Text] [Related]
6. Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using
Du X; Zhang W; Wang X; Yu X; Li Z; Guan Y
Front Endocrinol (Lausanne); 2021; 12():621456. PubMed ID: 34248835
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous ovarian hyperstimulation syndrome and pituitary adenoma: incidental pregnancy triggers a catastrophic event.
Baba T; Endo T; Kitajima Y; Kamiya H; Moriwaka O; Saito T
Fertil Steril; 2009 Jul; 92(1):390.e1-3. PubMed ID: 19356755
[TBL] [Abstract][Full Text] [Related]
8. Management of ovarian hyperstimulation due to follicle-stimulating hormone-secreting gonadotroph adenoma.
Murakami T; Higashitsuji H; Yoshinaga K; Terada Y; Ito K; Ikeda H
BJOG; 2004 Nov; 111(11):1297-300. PubMed ID: 15521879
[No Abstract] [Full Text] [Related]
9. Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone.
Ghayuri M; Liu JH
Obstet Gynecol; 2007 Feb; 109(2 Pt2):547-9. PubMed ID: 17267890
[TBL] [Abstract][Full Text] [Related]
10. Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman.
Sugita T; Seki K; Nagai Y; Saeki N; Yamaura A; Ohigashi S; Iwata A; Tatsuno I; Sekiya S
Gynecol Obstet Invest; 2005; 59(3):138-43. PubMed ID: 15637432
[TBL] [Abstract][Full Text] [Related]
11. Gonadotroph Pituitary Adenoma Causing Treatable Infertility and Ovarian Hyperstimulation Syndrome in Female Patients: Neurosurgical, Endocrinologic, Gynecologic, and Reproductive Outcomes.
Hasegawa H; Nesvick CL; Erickson D; Cohen SC; Yolcu YU; Khan Z; Raghunathan A; Nippoldt TB; Atkinson JL; Van Gompel JJ
World Neurosurg; 2021 Jun; 150():e162-e175. PubMed ID: 33684575
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas.
Knoepfelmacher M; Danilovic DL; Rosa Nasser RH; Mendonça BB
Fertil Steril; 2006 Sep; 86(3):719.e15-8. PubMed ID: 16952513
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
Chen SL; Yin MN; Sun L; Li H; Chen X; Song HD; He JX; Zhu L; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):588-90. PubMed ID: 17545062
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone.
Moon SY; Ku SY; Kim SM; Jee BC; Suh CS; Choi YM; Kim JG; Kim SH
J Obstet Gynaecol Res; 2005 Jun; 31(3):227-35. PubMed ID: 15916659
[TBL] [Abstract][Full Text] [Related]
15. Gonadotroph adenoma causing ovarian hyperstimulation syndrome in a premenopausal woman.
Halupczok J; Bidzińska-Speichert B; Lenarcik-Kabza A; Zieliński G; Filus A; Maksymowicz M
Gynecol Endocrinol; 2014 Nov; 30(11):774-7. PubMed ID: 24971660
[TBL] [Abstract][Full Text] [Related]
16. Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman--latent risk of unidentified ovarian hyperstimulation: a case report.
Kawaguchi T; Ogawa Y; Ito K; Watanabe M; Tominaga T
BMC Res Notes; 2013 Oct; 6():408. PubMed ID: 24119690
[TBL] [Abstract][Full Text] [Related]
17. Functioning gonadotroph adenoma with severe ovarian hyperstimulation syndrome: A new emergency in pituitary adenoma surgery? Surgical considerations and literature review.
Graillon T; Castinetti F; Chabert-Orsini V; Morange I; Cuny T; Albarel F; Brue T; Dufour H
Ann Endocrinol (Paris); 2019 Apr; 80(2):122-127. PubMed ID: 30825998
[TBL] [Abstract][Full Text] [Related]
18. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
Cavagna M; Maldonado LG; de Souza Bonetti TC; de Almeida Ferreira Braga DP; Iaconelli A; Borges E
Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
[TBL] [Abstract][Full Text] [Related]
20. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
Murata Y; Ando H; Nagasaka T; Takahashi I; Saito K; Fukugaki H; Matsuzawa K; Mizutani S
J Clin Endocrinol Metab; 2003 May; 88(5):1988-93. PubMed ID: 12727942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
